My Data, My Choice? – German Patient Organizations’ Attitudes towards Big Data-Driven Approaches in Personalized Medicine. An Empirical-Ethical Study

Personalized medicine (PM) operates with biological data to optimize therapy or prevention and to achieve cost reduction. Associated data may consist of large variations of informational subtypes e.g. genetic characteristics and their epigenetic modifications, biomarkers or even individual lifestyle...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauter, Carolin Martina, Wöhlke, Sabine, Schicktanz, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Systems-Level Quality Improvement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900081/
https://www.ncbi.nlm.nih.gov/pubmed/33616768
http://dx.doi.org/10.1007/s10916-020-01702-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900081/
https://www.ncbi.nlm.nih.gov/pubmed/33616768
http://dx.doi.org/10.1007/s10916-020-01702-7

Ejemplares similares